Table 1.
Participant demographics and clinical characteristics at baseline according to subsequent change in viral suppression status.
| Became Suppressed | Remained Suppressed | p Values | |
|---|---|---|---|
| 53 | 55 | -- | |
| Age—mean ± SD | 55 ± 8.5 | 58 ± 7.9 | 0.151 |
| Sex—N (%) female | 3 (5.8) | 12 (22.2) | 0.023 |
| Ethnicity—N (%) | 0.0874 | ||
| Black | 17 (41.5) | 24 (58.5) | -- |
| Hispanic | 5 (50) | 5 (50) | -- |
| Non-Hispanic white | 30 (57.7) | 22 (42.3) | -- |
| Other | 0 | 3 (100) | -- |
| Current CD4—median (IQR) | 579 (374–932) | 579 (358–784) | 0.618 |
| CD4 nadir—median (IQR) | 109 (26–237) | 67 (11–184) | 0.633 |